CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Not applicable	2026-06-30		NCT07234110

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Gaobo Boren Hospital	1
Institute of Hematology & Blood Diseases Hospital, China	285

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hematology Hospital of Chinese Academy of Medical Sciences	Tianjin	China	2

Clinical trials